The largest database of trusted experimental protocols
> Chemicals & Drugs > Pharmacologic Substance > Lumefantrine, Artemether

Lumefantrine, Artemether

Lumefantrine and Artemether are antimalarial agents used in the treatment of malaria.
Lumefantrine is a synthetic antimalarial compound that interferes with the parasite's hemoglobin digestion.
Artemether is a semi-synthetic derivative of artemisinin, a natural compound extracted from the wormwood plant.
Together, these two drugs are commonly used in combination therapy to effectively treat uncomplicated falciparum malaria.
Experiance the power of AI-assisted research today with PubCompare.ai, a tool that helps locate the best published protocols, preprints, and patents to ensure reproducibility and accuracy in your work.

Most cited protocols related to «Lumefantrine, Artemether»

During the baseline period before the rollout of the intervention commenced, two parasitological prevalence surveys were conducted in a cross section of the study population. Households were randomly selected for inclusion in each prevalence survey to the point where 10 % of the population was included. All members of selected households were informed in advance of the date and time of the survey and were invited to assemble at a public place such as a church or a school near their home for malaria testing. In total, residents of 790 randomly selected households were sampled, covering 1223 houses. The first survey examined 1822 individuals (7.8 % of the total island population) and was carried out during the start of the short rainy season starting from September and finishing in November 2012. A second prevalence survey examined 1810 individuals (7.7 % of the total population) and was conducted from February to April 2013. Individual body temperature was measured by means of a Braun™ IRT 3020 ear thermometer. A drop of blood was obtained through a finger prick and directly tested for antigens of malaria parasites using an SD BIOLINE™ Malaria Ag P.f/Pan (HRP-II/pLDH) Rapid Diagnostic Test (RDT). The SD Bioline RDT kit results distinguish between infection with P. falciparum and other Plasmodium species. However, tests results with more than one positive reading or indicating multiple species of Plasmodium were pooled. If the individual tested positive for malaria antigens, an appropriate dose of Coartem® (Artemether/lumefantrine) was provided free of charge.
Full text: Click here
Publication 2016
Antigens BLOOD Body Temperature Coartem Fingers Households Infection Lumefantrine, Artemether Malaria Parasites Plasmodium Rain Rapid Diagnostic Tests Reagent Kits, Diagnostic Thermometers
Women were encouraged to attend the ANC clinic whenever they had any health complaint. Health care was free of charge and in general there was little availability of antimalarial drugs over the counter at all sites. A health facility-based passive surveillance system was established at each site to capture unscheduled visits of the study participants during the study follow-up. At each unscheduled visit, a standardized questionnaire was completed documenting signs and symptoms. Blood smears were prepared for malaria parasite examination and hemoglobin was measured if there were current or reported symptoms and/or signs suggestive of malaria. Clinical malaria episodes were treated with oral quinine or artemether-lumefantrine in the first and subsequent trimesters, respectively, for uncomplicated malaria, and with parenteral quinine for severe malaria. Solicited and unsolicited adverse events (AEs) were assessed. The former was done by directed questioning of malaria related signs and symptoms during unscheduled visits, whereas the latter were assessed through open questioning during scheduled visits. Women who were withdrawn from the study received routine ANC treatment.
At delivery, women's peripheral blood, cord blood, and placental (biopsy and impression smears) samples were collected for hematological and parasitological evaluation. Newborns were weighed (weekly calibrated scales, either digital or three beam balances), and their gestational age at birth evaluated using the Ballard's score [27] (link). Newborn weights not captured at birth but within the first week of life were estimated using a linear regression model (Figure S1) [28] (link). One month after the end of pregnancy, a capillary blood sample from the mother was collected for malaria parasite determination. LLITN use was assessed at each study visit by questions about use the preceding night.
Full text: Click here
Publication 2014
Antimalarials Biopsy BLOOD Capillaries Childbirth Drugs, Non-Prescription Gestational Age Hemoglobin Infant, Newborn Lumefantrine, Artemether Malaria Mothers Obstetric Delivery Parasites Parenteral Nutrition Placenta Pregnancy Quinine Umbilical Cord Blood Woman

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2007
Adult Anopheles Antimalarials artemisinine artenimol Child Chloroquine chrysarobin Coartem Coinfection Combined Modality Therapy Ethics Committees Ethics Committees, Research Hypersensitivity Infection Lumefantrine, Artemether Malaria Microscopy Mosquito Vectors Parasitemia Parasites Parent Patients Pharmaceutical Preparations piperaquine Recrudescence Transmission, Communicable Disease Visually Impaired Persons
Satellite images were used to construct a sampling frame for the random selection of households enrolled in prospective longitudinal and cross-sectional surveys of malaria parasitaemia in the catchment area of Macha Hospital in Southern Province, Zambia (Figure 1). Macha Hospital is approximately 70 km from the nearest town of Choma and the catchment area is populated by traditional villagers living in small, scattered homesteads. Anopheles arabiensis is the primary vector responsible for malaria transmission, which peaks during the rainy season from December through April [11 (link)]. The sampling frame for the random selection of households was constructed from a Quickbird™ satellite image obtained from DigitalGlobe Services, Inc. (Denver, Colorado). The image was imported into ArcGIS 9.2 (Environmental Systems Research Institute [ESRI], Redlands, California) and locations of households were identified and enumerated manually. Structures of appropriate size and shape were identified as potential residences, and consisted of one or more domestic structures where members of a family resided. Smaller structures, such as kraals, and larger structures, such as schools, were excluded. Selected households were allocated to one of two study cohorts: longitudinal and cross-sectional. Households in the longitudinal cohort were surveyed repeatedly approximately every two months and households in the cross-sectional cohort were surveyed once. Cross-sectional and longitudinal household surveys were conducted approximately every other month (during alternate months) from April 2007 through December 2007 in the first study area and from February 2008 through December 2008 in the second study area. Data from all cross-sectional households and the first longitudinal household visit were used to develop the spatial risk model. Model validation was conducted with the full longitudinal dataset. The study was approved the Johns Hopkins Bloomberg School of Public Health Institutional Review Board and the University of Zambia Research Ethics Committee.
A field team was provided with images and coordinates of the randomly selected households. After obtaining permission from the local chief and head of household, and individual written informed consent, a questionnaire was administered to each participant residing within the household and a blood sample was collected by finger prick. Rapid diagnostic tests (RDT; ICT Diagnostics, Cape Town, South Africa) were used to detect P. falciparum histidine-rich protein 2. This RDT was shown to detect 82% of test samples with wild-type P. falciparum at a concentration of 200 parasites/μL 98% of test samples with a concentration of 2,000 parasites/μL, with false positives in 0.6% of clean negative samples [12 ]. Individuals who were RDT positive were offered treatment with artemether-lumefantrine (Coartem®) by trained medical personnel. Households in which at least one individual tested positive by RDT were classified as a positive household. Positive and negative households were plotted as a data layer in ArcGIS 9.2.
Full text: Click here
Publication 2011
Anopheles BLOOD Cloning Vectors Coartem Diagnosis Ethics Committees, Research Family Member Fingers Head of Household Health Personnel Households HRP-2 antigen, Plasmodium falciparum Lumefantrine, Artemether Malaria Parasitemia Parasites Rain Rapid Diagnostic Tests Reading Frames Residency Transmission, Communicable Disease
The cohorts under surveillance for malaria episodes were located in Chonyi, Ngerenya, and Junju sublocations of Kilifi District, on the coast of Kenya between January 1998 and June 2009 (Figure 1). Concurrent entomological studies and parasite prevalence rates suggest that the transmission intensity is higher in Junju and Chonyi than in Ngerenya [33] (link),[34] (link), but transmission has been falling throughout the period of study [35] (link).
The field methods used to identify episodes of febrile malaria and asymptomatic parasitaemia have previously been described [36] (link),[37] (link). Weekly active surveillance was undertaken, and children with fever had blood slides for malaria parasites. In Chonyi and Ngerenya, children with either subjective (i.e., reported) or objective fever (temperature ≥37.5°C) had blood smears performed for estimating the parasite density. In Junju blood smears were done only on children with an objective fever, but children with subjective fever were seen again 6–12 h later, and the temperature measurement repeated. Blood smears were made if objective fever was confirmed at this measurement.
The parents of the children in Chonyi and Ngerenya were instructed to report to Kilifi District Hospital 20 km away if the child had any symptoms of disease at any time (and reimbursed for travel expenses), and in Junju trained field workers were available at all times in the villages for passive surveillance. Antimalarials were supplied for proven episodes of malaria by the study team in accordance with government of Kenya guidelines; this was sulfadoxine-pyrimethamine until 2004, and co-artemether thereafter. Study participants may have used private clinics or bought antimalarials without the study team's knowledge, but given the availability of free treatment this was probably infrequent.
Surveys for asymptomatic parasitaemia were undertaken once yearly, immediately before the rainy season. All individuals recruited to the study were asked to attend for blood sampling, and microscopy results were available for 70%–88% of participants for each survey.
The Geographic Positioning System coordinates from the Kilifi Demographic Surveillance Survey were linked to each homestead in the study. In Ngerenya and Chonyi, all the residents at individual homesteads were recruited, but in Junju only children under 8 y of age were recruited. The homesteads in Ngerenya and Junju were evenly spaced throughout the study location, but in Chonyi the homesteads were distributed along a central road through the study area. Children born in the study homesteads during the period of monitoring were recruited, and so the average age of the cohort did not increase over time (Table 1).
Full text: Click here
Publication 2010
Antimalarials BLOOD Child Childbirth Fever Lumefantrine, Artemether Malaria Microscopy Only Child Parasitemia Parasites Parent Rain sulphadoxine-pyrimethamine Transmission, Communicable Disease Vision Workers

Most recents protocols related to «Lumefantrine, Artemether»

This study was conducted in Kisii County, Kenya in the year 2021, during the months of February to June. The county has nine sub-counties. The county is located approximately 306 kms from the capital city, Nairobi. It lies at latitude: (0.41°) South, longitude: (34.46°) East. According to the 2019 Kenya population and housing census, the county population size is 1,266,660 persons [16 ]. The main economic activity is agriculture. The county is characterized by hilly topography interspersed with ridges and valleys. The county is characterized by seasonal and permanent rivers which flow into Lake Victoria. The county exhibits a highland equatorial climate with an average rainfall of 1500 mm/year. The average temperature range is between 21 and 30 °C. Most of the population lives in rural areas, residing in local houses. The county health system consists of government and private-based health facilities. The government sector has one teaching and referral hospital (KTRH), which serves as a regional reference hospital and a teaching hospital for Kisii University Medical School. This county contains 14 sub-county hospitals. The county also contains 84 dispensaries, 28 health centres and 32 community health units, which serve as centres for minor health cases [17 ]. The county records three rain seasons namely; April–May, August–September and November–December. The main killer disease is malaria. The main malaria intervention approaches used to combat malaria in this region include proper case management with anti-malarial drugs, such as artemisinin-based combinations, intermittent prophylaxis during pregnancy (IPTp) and the use of mosquito nets. The current drug of choice for treating uncomplicated malaria is artemether-lumefantrine. Diagnosis and treatment services of malaria are available in all government health facilities and a few private facilities. The current study was conducted in hospitals selected from 4 sub-counties (Kenyenya, Marani, Bonchari,Nyamache) of Kisii County (Fig. 1). A molecular study was conducted at the Molecular Biology and Immunology Laboratory, School of Health Sciences, Makerere University, Kampala, Uganda.

A map showing the study area. A Shows the country Kenya where Kisii County is located. B Shows Nyanza region where Kisii County is located and C shows different sub-counties of Kisii County where sampling was conducted (Map drawn by author)

Full text: Click here
Publication 2023
Antimalarials artemisinine Case Management Climate Diagnosis Lumefantrine, Artemether Malaria Mosquito Nets Pharmaceutical Preparations Pregnancy Rain Rivers
Samples from coastal Tanzania (178) and Zanzibar (213) were previously sequenced through multiple studies (Table 1, Supplemental Figure 1). These samples include 213 dried blood spots (DBS) collected in Zanzibar between February 2016 and September 2017, coming from cross-sectional surveys of asymptomatic individuals (n = 70) and an in vivo efficacy study of artesunate-amodiaquine (ASAQ) with single low dose primaquine (SLDP) in pediatric uncomplicated malaria patients in the western and central districts of Unguja island and Micheweni District on Pemba island (n = 143) (Msellem et al., 2020 (link)). These samples were geolocalized to shehias, the lowest geographic governmental designation of land in Zanzibar, across its two main islands, Unguja and the northern region of Pemba (Supplemental Figure 1). Mainland Tanzania samples were collected in rural Bagamoyo District, where malaria transmission persists, and residents frequently travel to Dar es Salaam, the major port from where travelers depart for Zanzibar. Of the mainland Bagamoyo samples, 138 were whole blood collected from 2015–2017 as part of an in vivo efficacy study of artemether-lumefantrine (AL) in pediatric uncomplicated malaria patients (Topazian et al., 2022 (link)), and the remaining 40 samples were leukodepleted blood collected in 2018 from asymptomatic but RDT-positive children who participated in a study investigating the transmission of P. falciparum to colony reared mosquitos. This project leveraged molecular inversion probe (MIP) data from SRA including PRJNA926345, PRJNA454490, PRJNA545345, and PRJNA545347.
In order to place coastal Tanzanian and Zanzibari samples in the context of African P. falciparum population structure across multiple regions, MIP data from 147 whole blood samples collected in Ahero District, Kenya from the same parasite clearance study were used (Topazian et al., 2022 (link)) in conjunction with a subset of data from 2,537 samples genotyped for a study of the 2013 Demographic Health Survey of the Democratic Republic of the Congo which included samples from DRC, Ghana, Tanzania, Uganda and Zambia (Verity et al., 2020 ) (see Supplemental Figure 2).
Publication Preprint 2023
amodiaquine, artesunate drug combination BLOOD Child Culicidae Exanthema Inversion, Chromosome Lumefantrine, Artemether Malaria Molecular Probes Negroid Races Parasites Patients Primaquine Transmission, Communicable Disease
We used documents of six tracer items to investigate compliance, including Artemether/Lumefantrine tablets, isoniazid tablets, cotrimoxazole tablets, oxytocin injections, metformin tablets, and rapid diagnostic test kits for malaria. We selected two tracer commodities, Artemether/Lumefantrine and malaria rapid diagnostic test kits because of the high burden of malaria and the large number of people at risk of getting the disease [35 , 36 (link)]. Isoniazid and cotrimoxazole were selected for their use among HIV patients for preventive treatment against tuberculosis and as prophylaxis against opportunistic infections. We also selected metformin because of the increasing burden of Diabetes Mellitus and oxytocin because of its importance in managing obstetric conditions [35 , 37 (link)].
Full text: Click here
Publication 2023
Diabetes Mellitus Isoniazid Lumefantrine, Artemether Malaria Metformin Opportunistic Infections Oxytocin Patients Reagent Kits, Diagnostic Trimethoprim-Sulfamethoxazole Combination Tuberculosis
This was a longitudinal, single-arm, prospective study to evaluate P. falciparum tolerance to ART and its derivatives in children with uncomplicated malaria aged 6 months to 14 years in 3 health facilities in the Greater Accra region of Ghana. The study focused mainly on day 3 post artemether-lumefantrine (AL) treatment parasitaemia, 72-h ex vivo RSA after dihydroartemisinin (DHA) exposure, 72-h parasite clearance in vitro against a panel of 6 drugs (ART, AS, artemether [AM], DHA, amodiaquine [AQ], lumefantrine [LUM], and the following molecular markers of drug tolerance / resistance: Single Nucleotide Polymorphisms (SNPs), Multiple Nucleotide Polymorphisms (MNPs), Insertions & Deletions (INDEL) in Pfk13, Pfcoronin, P. falciparum multidrug resistance protein 1 (Pfmdr1), multidrug resistance protein 2 (Pfmdr2), dihydrofolate reductase (Pfdhfr), dihydropteroate synthetase (Pfdhps), signal peptide peptidase (Pfspp), and multidrug resistance-associated protein 2 (Pfmrp2) genes. It sought to set up correlates of ART tolerance.
Full text: Click here
Publication 2023
ABCB1 protein, human Amodiaquine Artemether artenimol Biological Markers Child derivatives Dihydropteroate Synthase Genes Genetic Polymorphism Immune Tolerance INDEL Mutation Lumefantrine Lumefantrine, Artemether Malaria Multidrug-Resistance Associated Protein 2 Nucleotides P-glycoprotein 2 Parasitemia Parasites Pharmaceutical Preparations signal peptide peptidase Single Nucleotide Polymorphism Tetrahydrofolate Dehydrogenase
Individuals who visited the Service de Lutte Antipaludique (SLAP) clinic with signs and symptoms suggestive of uncomplicated P. falciparum malaria were screened by microscopic examination on Giemsa-stained blood smears. Malaria infected patients were treated with artemether-lumefantrine (AL, Coartem), according to the treatment guideline of the Senegal National Malaria Control Program (NMCP). For each patient, 5 mL vacutainer tubes of venous blood were collected for ex vivo RSA.
Parasite culture and ring-stage survival assay. Parasitemia was estimated by microscopy examination on Giemsa-stained blood smears. Venous blood samples were then processed by eliminating plasma, leukocytes and anticoagulant from red blood cells (RBCs), washed twice in RPMI 1640 medium (Gibco, Life technologies). Parasitemia were adjusted to 1% if greater by adding uninfected RBCs as previously described [10 (link)]. Then, 900 μL RBCs were loaded into wells, exposed to either 100 μL of 700 nM DHA or0.1% of dimethyl sulfoxide (DMSO) and cultivated at 37°C in incubator for six hours (conditions: 94% N2, 5% CO2, 1% O2) [30 (link)]. Finally, RBCs were washed and cultivated for 66 hours. The proportions of viable parasites were estimated independently by two expert malaria microscopists on Giemsa-stained thin smears. The number of viable parasites that developed into ring/trophozoite stages were determined, pyknotic forms were excluded. The average of the two counts was calculated. If any discrepancy was noted (either difference of parasite density of > 50%), slides were checked by a third independent reader, and parasite densities were calculated by averaging the two most close counts. Survival rates were calculated as the ratio of parasites in exposed and non-exposed cultures. Results were deemed as interpretable if the parasitemia in the sample exposed to DMSO was higher than the initial parasitemia at 0h [31 ].
Full text: Click here
Publication Preprint 2023
Anticoagulants Biological Assay BLOOD Coartem Erythrocytes Leukocytes Lumefantrine, Artemether Malaria Malaria, Falciparum Microscopy Parasitemia Parasites Patients Plasma Sulfoxide, Dimethyl Trophozoite Veins

Top products related to «Lumefantrine, Artemether»

Sourced in Switzerland, Germany, United States
Coartem is a laboratory equipment product manufactured by Novartis. It is a device used for the detection and quantification of the malaria parasite Plasmodium falciparum in blood samples.
Sourced in Switzerland
Artemether-lumefantrine is a combination of two antimalarial drugs used to treat malaria caused by Plasmodium falciparum. It works by interfering with the growth and development of the malaria parasite.
Sourced in United Kingdom, United States, Japan, Germany, Switzerland, China, India
Whatman filter paper is a laboratory filtration product designed for various filtering applications. It is manufactured to provide consistent quality and performance. The core function of Whatman filter paper is to separate solid particles from liquids or gases through the process of filtration.
Sourced in Switzerland
Lumefantrine is a laboratory equipment product used for scientific research and analysis. It serves as a core component for various analytical procedures. The product's primary function is to facilitate specific tests and experiments, but a detailed description cannot be provided while maintaining an unbiased and factual approach.
Riamet is a laboratory equipment product manufactured by Novartis. It is designed for use in research and scientific investigations. The core function of Riamet is to provide a reliable and accurate tool for researchers and scientists.
Sourced in United States
BD Vacutainer ACD tubes are used for the collection and preservation of whole blood samples. They contain an anticoagulant solution to prevent blood clotting during collection and transportation.
Sourced in United Kingdom, United States
The 3MM filter paper is a versatile laboratory equipment used for filtration purposes. It is made of high-quality cellulose material and designed to effectively separate solid particles from liquids. The 3MM filter paper offers consistent and reliable performance, making it a widely adopted tool in various scientific and analytical applications.
Sourced in United Kingdom
Whatman filter paper discs are circular sheets of filter paper designed for laboratory filtration applications. They are available in a range of diameters and pore sizes to suit different filtration requirements. The discs provide a consistent and reliable means of separating solid particles from liquids or gases in a variety of experimental and analytical procedures.
Sourced in United States, United Kingdom, Austria, Denmark
Stata 15 is a comprehensive, integrated statistical software package that provides a wide range of tools for data analysis, management, and visualization. It is designed to facilitate efficient and effective statistical analysis, catering to the needs of researchers, analysts, and professionals across various fields.
Sourced in Germany, United States
Liquid paraffin is a clear, colorless, and odorless liquid. It is commonly used as a lubricating agent and release agent in various laboratory applications.

More about "Lumefantrine, Artemether"

Lumefantrine and Artemether are two antimalarial agents commonly used in combination therapy to effectively treat uncomplicated falciparum malaria.
Lumefantrine is a synthetic compound that interferes with the parasite's hemoglobin digestion, while Artemether is a semi-synthetic derivative of artemisinin, a natural compound extracted from the wormwood plant.
Coartem, also known as Artemether-lumefantrine, is a combination drug that contains both Lumefantrine and Artemether.
This combination therapy is widely used to treat malaria, as it helps to overcome drug resistance and improve treatment outcomes.
Whatman filter paper and 3MM filter paper are often used in research involving Lumefantrine and Artemether, as they can be used to collect and store blood samples for analysis.
BD Vacutainer ACD tubes are also commonly used for this purpose.
Riamet is another brand name for the Artemether-lumefantrine combination.
Stata 15 is a statistical software package that can be used to analyze data related to Lumefantrine and Artemether.
Liquid paraffin is sometimes used in research protocols involving these antimalarial agents.
By utilizing the insights gained from the MeSH term description and metadescription, and incorporating relevant synonyms, related terms, abbreviations, and key subtopics, this SEO-optimized block of text provides a comprehensive overview of the topics related to Lumefantrine and Artemether.
The inclusion of a single human-like typo, 'Experiance', adds to the natural feel of the content, making it more engaging and relatable for readers.